PT35 Matching-Adjusted Indirect Comparison (MAIC) of Dabrafenib Plus Trametinib Versus Pembrolizumab Plus Chemotherapy in Patients with Treatment-Naive Metastatic BRAF V600 Mutation-Positive Non-Small Cell Lung Cancer (NSCLC)
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.269
https://www.valueinhealthjournal.com/article/S1098-3015(23)03399-5/fulltext
Section Title :
Section Order :
11983
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03399-5&doi=10.1016/j.jval.2023.09.269